This activity is intended for internal CCAD Physicians

Activity Description:

This activity's learning needs are identified based multiple inputs: individual participant feed-backs, Morbidity and mortality meetings, other critical event reporting system, new Institute and Institution-wide policies, establishment of new service line, etc.

Target Audience: 

Infectious Disease Physicians - Pharmacists

Learning Objectives:

Participants will be able to achieve the below:

• Apply updated evidence-based guidelines to complex infections disease cases
• Improve diagnostic reasoning in challenging ID presentation
• Optimize antimicrobial selection, duration, and stewardship considerations 
• Identify system-level and patient-safety learning points from real cases
• Promote multidisciplinary collaboration in clinical decision-making

Faculty Disclosure:

In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Abu Dhabi for Continuing Education mitigates all faculty conflicts of interest to ensure CME activities are free of commercial bias.

Activity Director(s): Mohamad Yehya Mooty, MD

The planning committee, faculty, and others in control of content (either individually or as a group) have NO relevant financial relationship(s) to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation Statement:

Cleveland Clinic Abu Dhabi for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for to provide continuing education for the healthcare team.

Credit Designation:

This activity was designated for 1.00 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.